서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 19 of 19

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2015-11	The distinct signatures of VEGF and soluble VEGFR2 increase prognostic implication in gastric cancer Ock, Chan-Young; Nam, Ah-Rong; Bang, Ju-Hee; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn American Journal of Cancer Research, Vol.5 No.11, pp.3376-3388
2016-07	Src as a Therapeutic Target in Biliary Tract Cancer Nam, Ah-Rong; Kim, Ji-Won; Park, Ji Eun; Bang, Ju-Hee; Jin, Mei Hua; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.15 No.7, pp.1515-1524	DOI
2016-09	Therapeutic implication of HER2 in advanced biliary tract cancer Nam, Ah-Rong; Kim, Ji-Won; Cha, Yongjun; Ha, Hyerim; Park, Ji Eun; Bang, Ju-Hee; Jin, Mei Hua; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Oncotarget, Vol.7 No.36, pp.58007-58021	DOI
2016-11	Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy Ha, Hyerim; Nam, Ah-Rong; Bang, Ju-Hee; Park, Ji-Eun; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Oncotarget, Vol.7 No.47, pp.76604-76612	DOI
2017-01	Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer Ock, Chan-Young; Nam, Ah-Rong; Bang, Ju-Hee; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Gastric Cancer, Vol.20 No.1, pp.164-174	DOI
2017-03	Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer Ock, Chan-Young; Nam, Ah-Rong; Lee, Joongyub; Bang, Ju-Hee; Lee, Kyung-Hun; Han, Sae-Won; Kim, Tae-Yong; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Gastric Cancer, Vol.20 No.2, pp.254-262	DOI
2017-06	Resistance Mechanism against Trastuzumab in HER2-Positive Cancer Cells and Its Negation by Src Inhibition Jin, Mei Hua; Nam, Ah-Rong; Park, Ji Eun; Bang, Ju-Hee; Bang, Yung-Jue; Oh, Do-Youn Molecular Cancer Therapeutics, Vol.16 No.6, pp.1145-1154	DOI
2017-12	Anti-tumor effects of NVP-BKM120 alone or in combination with MEK162 in biliary tract cancer Jin, Ling; Jin, Mei-hua; Nam, Ah-Rong; Park, Ji-Eun; Bang, Ju-Hee; Oh, Do Yeun; Bang, Yung Jue Cancer Letters, Vol.411, pp.162-170	DOI
2019-04	Dynamics of soluble programmed death-ligand 1 (SPDL1) during chemotherapy and its prognostic implications in cancer patients: Biomarker development in immuno-oncology Ha, Hyerim; Bang, Ju-Hee; Nam, Ah-Rong; Park, Ji-Eun; Jin, Mei Hua; Bang, Yung-Jue; Oh, Do-Youn Cancer Research and Treatment, Vol.51 No.2, pp.832-840	DOI
2019-07	Therapeutic targeting of the DNA damage response using an ATR inhibitor in biliary tract cancer Nam, Ah-Rong; Jin, Mei Hua; Park, Ji Eun; Bang, Ju-Hee; Oh, Do-Youn; Bang, Yung-Jue Cancer Research and Treatment, Vol.51 No.3, pp.1167-1179	DOI
2019-07	Jab1 silencing inhibits proliferation and sensitizes to cisplatin in biliary tract cancer Nam, Ah-Rong; Kim, Ji-Won; Park, Ji Eun; Bang, Ju-Hee; Jin, Mei Hua; Oh, Do-Youn; Bang, Yung-Jue Cancer Research and Treatment, Vol.51 No.3, pp.886-900	DOI
2019-08	Enhanced antitumor effect of binimetinib in combination with capecitabine for biliary tract cancer patients with mutations in the RAS/RAF/MEK/ERK pathway: Phase Ib study Kim, Jin Won; Lee, Kyung-Hun; Kim, Ji-Won; Suh, Koung Jin; Nam, Ah-Rong; Bang, Ju-Hee; Bang, Yung-Jue; Oh, Do-Youn British Journal of Cancer, Vol.121 No.4, pp.332-339	DOI
2019-09	GC1118, a novel anti-EGFR antibody, has potent KRAS mutation-independent antitumor activity compared with cetuximab in gastric cancer Park, Ji Eun; Jin, Mei Hua; Hur, Minkyu; Nam, Ah-Rong; Bang, Ju-Hee; Won, Jonghwa; Oh, Do-Youn; Bang, Yung-Jue Gastric Cancer, Vol.22 No.5, pp.932-940	DOI
2019-12	Prognostic implications of soluble programmed death-ligand 1 and its dynamics during chemotherapy in unresectable pancreatic cancer Park, Hyunkyung; Bang, Ju-Hee; Nam, Ah-Rong; Park, Ji Eun; Jin, Mei Hua; Bang, Yung-Jue; Oh, Do-Youn Scientific Reports, Vol.9 No.1, p. 11131	DOI
2020-01	Therapeutic Co-targeting of WEE1 and ATM Downregulates PD-L1 Expression in Pancreatic Cancer Jin, Mei Hua; Nam, Ah-Rong; Park, Ji Eun; Bang, Ju-Hee; Bang, Yung-Jue; Oh, Do-Youn Cancer Research and Treatment, Vol.52 No.1, pp.149-166	view file DOI
2020-01	The prognostic role of soluble TGF-beta and its dynamics in unresectable pancreatic cancer treated with chemotherapy Park, Hyunkyung; Bang, Ju-Hee; Nam, Ah-Rong; Park, Ji Eun; Jin, Mei Hua; Bang, Yung-Jue; Oh, Do-Youn Cancer Medicine, Vol.9 No.1, pp.43-51	DOI
2020-01	The prognostic role of soluble TGF-beta and its dynamics in unresectable pancreatic cancer treated with chemotherapy Park, Hyunkyung; Bang, Ju-Hee; Nam, Ah-Rong; Park, Ji Eun; Jin, Mei Hua; Bang, Yung-Jue; Oh, Do-Youn Cancer Medicine, Vol.9 No.1, pp.43-51	DOI
2020-07	Inhibition of ATR Increases the Sensitivity to WEE1 Inhibitor in Biliary Tract Cancer Nam, Ah-Rong; Jin, Mie-Hua; Bang, Ju-Hee; Oh, Kyoung-Seok; Seo, Hye-Rim; Oh, Do-Youn; Bang, Yung-Jue Cancer Research and Treatment, Vol.52 No.3, pp.945-956	view file DOI
2022-06	Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study Oh, Do-Youn; Lee, Kyung-Hun; Lee, Dae-Won; Yoon, Jeesun; Kim, Tae-Yong; Bang, Ju-Hee; Nam, Ah-Rong; Oh, Kyoung-Seok; Kim, Jae-Min; Lee, Young; Guthrie, Violeta; McCoon, Patricia; Li, Weimin; Wu, Song; Zhang, Qu; Rebelatto, Marlon C; Kim, Jin Won The Lancet Gastroenterology & Hepatology, Vol.7 No.6, pp.522-532	DOI

1